The regulatory landscape for actively personalized cancer immunotherapies

Cedrik M. Britten, Harpreet Singh-Jasuja, Bruno Flamion, Axel Hoos, Christoph Huber, Karl Josef Kallen, Samir N. Khleif, Sebastian Kreiter, Michaela Nielsen, Hans Georg Rammensee, Ugur Sahin, Thomas Hinz, Ulrich Kalinke

Research output: Contribution to journalLetter

33 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)880-882
Number of pages3
JournalNature Biotechnology
Volume31
Issue number10
DOIs
StatePublished - Oct 1 2013

Fingerprint

Precision Medicine
Cancer Vaccines
Tumor Biomarkers
Immunotherapy
Neoplasms

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology
  • Molecular Medicine
  • Biomedical Engineering

Cite this

Britten, C. M., Singh-Jasuja, H., Flamion, B., Hoos, A., Huber, C., Kallen, K. J., ... Kalinke, U. (2013). The regulatory landscape for actively personalized cancer immunotherapies. Nature Biotechnology, 31(10), 880-882. https://doi.org/10.1038/nbt.2708

The regulatory landscape for actively personalized cancer immunotherapies. / Britten, Cedrik M.; Singh-Jasuja, Harpreet; Flamion, Bruno; Hoos, Axel; Huber, Christoph; Kallen, Karl Josef; Khleif, Samir N.; Kreiter, Sebastian; Nielsen, Michaela; Rammensee, Hans Georg; Sahin, Ugur; Hinz, Thomas; Kalinke, Ulrich.

In: Nature Biotechnology, Vol. 31, No. 10, 01.10.2013, p. 880-882.

Research output: Contribution to journalLetter

Britten, CM, Singh-Jasuja, H, Flamion, B, Hoos, A, Huber, C, Kallen, KJ, Khleif, SN, Kreiter, S, Nielsen, M, Rammensee, HG, Sahin, U, Hinz, T & Kalinke, U 2013, 'The regulatory landscape for actively personalized cancer immunotherapies', Nature Biotechnology, vol. 31, no. 10, pp. 880-882. https://doi.org/10.1038/nbt.2708
Britten CM, Singh-Jasuja H, Flamion B, Hoos A, Huber C, Kallen KJ et al. The regulatory landscape for actively personalized cancer immunotherapies. Nature Biotechnology. 2013 Oct 1;31(10):880-882. https://doi.org/10.1038/nbt.2708
Britten, Cedrik M. ; Singh-Jasuja, Harpreet ; Flamion, Bruno ; Hoos, Axel ; Huber, Christoph ; Kallen, Karl Josef ; Khleif, Samir N. ; Kreiter, Sebastian ; Nielsen, Michaela ; Rammensee, Hans Georg ; Sahin, Ugur ; Hinz, Thomas ; Kalinke, Ulrich. / The regulatory landscape for actively personalized cancer immunotherapies. In: Nature Biotechnology. 2013 ; Vol. 31, No. 10. pp. 880-882.
@article{ac813b26b4a945a6808c082f0b601fc9,
title = "The regulatory landscape for actively personalized cancer immunotherapies",
author = "Britten, {Cedrik M.} and Harpreet Singh-Jasuja and Bruno Flamion and Axel Hoos and Christoph Huber and Kallen, {Karl Josef} and Khleif, {Samir N.} and Sebastian Kreiter and Michaela Nielsen and Rammensee, {Hans Georg} and Ugur Sahin and Thomas Hinz and Ulrich Kalinke",
year = "2013",
month = "10",
day = "1",
doi = "10.1038/nbt.2708",
language = "English (US)",
volume = "31",
pages = "880--882",
journal = "Nature Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - The regulatory landscape for actively personalized cancer immunotherapies

AU - Britten, Cedrik M.

AU - Singh-Jasuja, Harpreet

AU - Flamion, Bruno

AU - Hoos, Axel

AU - Huber, Christoph

AU - Kallen, Karl Josef

AU - Khleif, Samir N.

AU - Kreiter, Sebastian

AU - Nielsen, Michaela

AU - Rammensee, Hans Georg

AU - Sahin, Ugur

AU - Hinz, Thomas

AU - Kalinke, Ulrich

PY - 2013/10/1

Y1 - 2013/10/1

UR - http://www.scopus.com/inward/record.url?scp=84885659334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885659334&partnerID=8YFLogxK

U2 - 10.1038/nbt.2708

DO - 10.1038/nbt.2708

M3 - Letter

C2 - 24104749

AN - SCOPUS:84885659334

VL - 31

SP - 880

EP - 882

JO - Nature Biotechnology

JF - Nature Biotechnology

SN - 1087-0156

IS - 10

ER -